+

WO2002066643A3 - Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation - Google Patents

Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation Download PDF

Info

Publication number
WO2002066643A3
WO2002066643A3 PCT/US2001/048732 US0148732W WO02066643A3 WO 2002066643 A3 WO2002066643 A3 WO 2002066643A3 US 0148732 W US0148732 W US 0148732W WO 02066643 A3 WO02066643 A3 WO 02066643A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
methods
same
polynucleotides encoding
disclosed
Prior art date
Application number
PCT/US2001/048732
Other languages
English (en)
Other versions
WO2002066643A2 (fr
Inventor
Uriel M Malyankar
Suresh G Shenoy
Kimberly A Spytek
Bryan D Zerhusen
Meera Patturajan
Xiaojia Guo
Ramesh Kekuda
Esha A Gangolli
Richard A Shimkets
Raymond J Taupier Jr
Li Li
Muralidhara Padigaru
Original Assignee
Curagen Corp
Uriel M Malyankar
Suresh G Shenoy
Kimberly A Spytek
Bryan D Zerhusen
Meera Patturajan
Xiaojia Guo
Ramesh Kekuda
Esha A Gangolli
Richard A Shimkets
Raymond J Taupier Jr
Li Li
Muralidhara Padigaru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Uriel M Malyankar, Suresh G Shenoy, Kimberly A Spytek, Bryan D Zerhusen, Meera Patturajan, Xiaojia Guo, Ramesh Kekuda, Esha A Gangolli, Richard A Shimkets, Raymond J Taupier Jr, Li Li, Muralidhara Padigaru filed Critical Curagen Corp
Publication of WO2002066643A2 publication Critical patent/WO2002066643A2/fr
Publication of WO2002066643A3 publication Critical patent/WO2002066643A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique qui codent pour de nouveaux polypeptides. L'invention concerne également les polypeptides codés par ces séquences d'acide nucléique, et des anticorps qui se lient de manière immunospécifique avec ces polypeptides, ainsi que des dérivés, des variants, des mutants ou des fragments des poylpeptides, polynucléotides ou anticorps décrits. L'invention concerne en outre des méthodes de traitement, de diagnostic et de recherche destinées au diagnostic, au traitement et à la prévention de troubles associés à l'un de ces nouveaux acides nucléiques et protéines humains.
PCT/US2001/048732 2000-11-13 2001-11-13 Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation WO2002066643A2 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US60/248,153 2000-11-13
US24959800P 2000-11-17 2000-11-17
US60/249,598 2000-11-17
US26424001P 2001-01-26 2001-01-26
US60/264,240 2001-01-26
US26612701P 2001-02-02 2001-02-02
US60/266,127 2001-02-02
US26956201P 2001-02-16 2001-02-16
US60/269,562 2001-02-16
US30434801P 2001-07-10 2001-07-10
US60/304,348 2001-07-10
US30926101P 2001-07-31 2001-07-31
US60/309,261 2001-07-31
US31328301P 2001-08-17 2001-08-17
US60/313,283 2001-08-17

Publications (2)

Publication Number Publication Date
WO2002066643A2 WO2002066643A2 (fr) 2002-08-29
WO2002066643A3 true WO2002066643A3 (fr) 2003-06-26

Family

ID=27569466

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048732 WO2002066643A2 (fr) 2000-11-13 2001-11-13 Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation

Country Status (1)

Country Link
WO (1) WO2002066643A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
WO2002074906A2 (fr) * 2001-03-16 2002-09-26 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
EP2069793B9 (fr) 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identification d'une protéine associée à un carcinome hépatocellulaire, à un glioblastome et à un cancer du poumon
EP1918299A1 (fr) * 2006-11-03 2008-05-07 Universite De Geneve Modulateurs de molécules d'adhésion cellulaire et leur utilisation
WO2008142693A2 (fr) * 2007-05-22 2008-11-27 Yeda Research And Development Co. Ltd. Régulation de la myélination par des molécules de type nectine (necl)
ES2639026T3 (es) 2009-03-05 2017-10-25 Oxford Biotherapeutics Ltd. Anticuerpos totalmente humanos específicos para CADM1
EP2878335B1 (fr) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant et système d'implantation pour stimulateur neural
EP3093043B1 (fr) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant et système de distribution pour stimulateur neural

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004263A1 (fr) * 1997-07-17 1999-01-28 The John Hopkins University School Of Medicine Recepteur de semaphorine
WO2001029215A2 (fr) * 1999-10-19 2001-04-26 Compugen Ltd. Homologues de molecules d'adherence cellulaire neuronale
WO2002038744A2 (fr) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Protéases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004263A1 (fr) * 1997-07-17 1999-01-28 The John Hopkins University School Of Medicine Recepteur de semaphorine
WO2001029215A2 (fr) * 1999-10-19 2001-04-26 Compugen Ltd. Homologues de molecules d'adherence cellulaire neuronale
WO2002038744A2 (fr) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Protéases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OSADA N ET AL: "Macaca fascicularis brain cDNA, clone:QccE-16296", EMBL, XP002173301 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation

Also Published As

Publication number Publication date
WO2002066643A2 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
WO2002014368A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002006339A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002064791A3 (fr) Proteines et acides nucleiques codant celles-ci
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2002050277A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2002057453A3 (fr) Polypeptides et acides nucleiques codant ces derniers
WO2002057450A3 (fr) Proteines et acides nucleiques les codant
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2002081518A3 (fr) Proteines, polynucleotides les codant et leurs procedes d'utilisation
WO2002029058A3 (fr) Nouvelles proteines humaines, polynucleotides codant pour ces proteines et methodes d'utilisation associees
WO2001060990A3 (fr) Nouvelles kinases de sphingosine
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2001090155A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002098917A3 (fr) Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
WO2001081578A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2001029217A3 (fr) Polypeptides, et polynucleotides codant ces polypeptides
WO2002081510A3 (fr) Proteines, polynucleotides codant pour celles-ci et methodes d'utilisation
WO2002016599A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002066643A3 (fr) Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation
WO2002055704A3 (fr) Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants
WO2002046229A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002029038A3 (fr) Nouvelles proteines, acides nucleiques codant ces derniers et anticorps diriges contre ces proteines
WO2002000691A3 (fr) Nouveaux polynucleotides et polypeptides codes par ceux-ci
WO2002055702A3 (fr) Protéines humaines, polynucléotides les codant et procédés d'utilisation correspondants
WO2002010216A3 (fr) Nouvelles proteines et acides nucleiques codant pour elles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载